Edge Therapeutics Inc (NASDAQ:EDGE)

1.03
Delayed Data
As of Jul 17
 0.00 / 0.00%
Today’s Change
0.84
Today|||52-Week Range
17.77
-89.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$31.6M

Company Description

Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.

Contact Information

Edge Therapeutics, Inc.
300 Connell Drive
Berkeley Heights New Jersey 07922
P:(800) 208-3343
Investor Relations:

Employees

Shareholders

Other institutional6.46%
Individual stakeholders31.19%
Mutual fund holders10.05%

Top Executives

Brian A. LeuthnerPresident, Chief Executive Officer & Director
Andrew SaikChief Financial Officer
Herbert J. FaleckChief Medical Officer
W. Bradford MiddlekauffSecretary, Senior Vice President & General Counsel
Albert N. MarchioChief Accounting & Administrative Officer